Javanbakht, Mehdi
Fishman, Jesse
Moloney, Eoin
Rydqvist, Peter
Ansaripour, Amir http://orcid.org/0000-0002-9298-6393
Funding for this research was provided by:
Madrigal Pharmaceutical
Article History
Accepted: 24 August 2022
First Online: 14 September 2022
Declarations
:
: This research was funded by Madrigal Pharmaceuticals, Inc. The views expressed in this publication are those of the author(s) and not necessarily those of the company.
: MJ, EM, and AA are employees of Optimax Access Ltd., which has received research grants from Madrigal Pharmaceuticals, Inc. JF and PR are employees of Madrigal Pharmaceuticals, Inc., which funded the study.
: Not applicable.
: Not applicable.
: Not applicable.
: The model used in this study was provided to the journal’s peer reviewers for their reference when reviewing the manuscript. The information reported in this manuscript is sufficient to replicate the results of the study.
: Code used to perform the economic modeling was provided to the journal’s peer reviewers for their reference when reviewing the manuscript. The information reported in this manuscript is sufficient to replicate the results of the study.